$LDX is cooked. No wonder they rushed for the CR - they probably have no decent announcements for the next 6 months or so.
And what's with the "CLIA Waiver was submitted in August", when FDA shows it was received on 10th of March, just 2 weeks before approval:
My $LDX prediction:
- Open: ~30% gap up ($0.34–$0.35 range)
- Short-term: Profit-taking back to $0.24–$0.25 (just above CR price)
- Outlook: Bullish after the dust settles.
Does it usually bounce $NXT, $NXT.AX? Worth the wait or just forget it? I thought mentioning OpenAI will run to the moon :)) Never followed it, so have no clue about FA
